Cryptophycin 1 cellular levels and effects in vitro using L1210 cells Brenda J. FosterMike FortunaFrederick A. Valeriote OriginalPaper Pages: 199 - 204
The folate receptor as a potential therapeutic anticancer target Barbara A. GrunerSteven D. Weitman OriginalPaper Pages: 205 - 219
Effects of SW 33377, SW 68210 and SW 71425 thioxanthones on in vitro colony formation of freshly explanted human tumor cells Elzbieta IzbickaRichard LawrenceDaniel D. Von Hoff OriginalPaper Pages: 221 - 225
Compatibility and stability of bryostatin 1 in infusion devices Andrew P. CheungYali F. HallockEuphemia Wang OriginalPaper Pages: 227 - 236
Phase I study of paclitaxel administered by ten-day continuous infusion Ronald J. ShadeKatherine M.W. PistersJin Soo Lee OriginalPaper Pages: 237 - 243
Phase I and pharmacologic study of oral (E)-2′-deoxy-2′-(fluoromethylene) cytidine: on a daily × 5-day schedule Noriyuki MasudaShunichi NegoroMasahiro Fukuoka OriginalPaper Pages: 245 - 254
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer Kumar RajagopalanDavid PeereboomRonald Bukowski OriginalPaper Pages: 255 - 258
A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687) Howard HochsterRuth OratzErnest Borden OriginalPaper Pages: 259 - 263
Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience J. LatreilleK.A. GelmonJ. Bérille OriginalPaper Pages: 265 - 270
Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study Wolfram E. SamlowskiDanika LewJohn F. Ensley OriginalPaper Pages: 271 - 274
Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer Sridhar ManiJohn W. KuglerEverett E. Vokes OriginalPaper Pages: 275 - 278
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma Sridhar ManiThomas SchianoEverett E. Vokes OriginalPaper Pages: 279 - 283